01 / Contract Profile
75A50122C00008 Federal Contract Award
Agency code 7505
HIGH THROUGHPUT SARS-COV-2 NEUTRALIZING ANTIBODY IMMUNOASSAY FOR QUALIFYING VARIANTS AND TESTING OF HUMAN SERUM SAMPLES.
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75A50122C00008 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$0
FY 2026Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2021 | $20.37M | 1 | — |
| FY 2022 | $33.25M | 3 | +63.3% |
| FY 2023 | -$612 | 4 | −100.0% |
| FY 2025 | -$15.61M | 3 | −2,552,966.2% |
| FY 2026 | $0 | 1 | +100.0% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA |
05 / Contractor
Who holds this federal contract?
MONOGRAM BIOSCIENCES, INC.
UEI LFM3XDVK31M7 · CAGE 3XFL0
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $38.01M | 12 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $38.01M | 12 | 100.0% |
08 / Place of Performance
Where is the work recorded?
SOUTH SAN FRANCISCO, SAN MATEO, CALIFORNIA, UNITED STATES
ZIP 940801913
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Mar 4, 2026 | P00011 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 24, 2025 | P00010 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 15, 2025 | P00009 | -$15.61M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Jun 17, 2025 | P00008 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 15, 2023 | P00007 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Jun 8, 2023 | P00006 | -$342 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Jan 27, 2023 | P00005 | -$270 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Jan 11, 2023 | P00004 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Jun 29, 2022 | P00003 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Jun 8, 2022 | P00002 | $33.25M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| May 26, 2022 | P00001 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Nov 29, 2021 | Base action | $20.37M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.